HBM US

HBM US is a wholly-owned subsidiary of Harbour BioMed. HBM US is a biopharmaceutical company focused on the research, development, and commercialization of innovative drugs, creating novel biologics with significant clinical value for the treatment of oncology and immunological diseases.